Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.6K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

117
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
117

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An approach to nonparametric inference on the causal dose-response function.

Journal of causal inference·2026
Same author

UNLOCKING MULTI-SAMPLE DIFFERENTIAL EXPRESSION FOR SPATIAL TRANSCRIPTOMICS DATA WITH TESSERA.

bioRxiv : the preprint server for biology·2026
Same author

Sequential invitations to FOBT screening and colorectal cancer incidence.

Scientific reports·2026
Same author

Powering RCTs for Marginal Effects With GLMs Using Prognostic Score Adjustment.

Statistics in medicine·2026
Same author

Machine learning to optimize precision in the analysis of randomized trials: A journey in pre-specified, yet data-adaptive learning.

Clinical trials (London, England)·2026
Same author

Assessing Treatment Effects in Observational Data With Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods.

Statistics in medicine·2026

Related Experiment Video

Updated: Sep 4, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K

A flexible approach for predictive biomarker discovery.

Philippe Boileau1, Nina Ting Qi2, Mark J van der Laan3

  • 1Graduate Group in Biostatistics and Center for Computational Biology, University of California, Berkeley, Berkeley, CA 94720, USA.

Biostatistics (Oxford, England)
|July 21, 2022
PubMed
Summary
This summary is machine-generated.

This study introduces a new method for discovering predictive biomarkers in precision medicine, improving accuracy and reducing false discoveries in clinical trials. The approach helps identify patient subgroups likely to respond to treatments, optimizing drug development and patient outcomes.

Keywords:
Heterogeneous treatment effectsHigh-dimensional dataNonparametric statisticsPrecision medicinePredictive biomarkersVariable importance

More Related Videos

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.1K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

450

Related Experiment Videos

Last Updated: Sep 4, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.6K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.1K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

450

Area of Science:

  • Biostatistics
  • Genomics
  • Precision Medicine

Background:

  • Predictive biomarker discovery is crucial for precision medicine, identifying patient subgroups for targeted therapies.
  • Current methods often conflate biomarker discovery with treatment rule estimation, leading to high false discovery rates in high-dimensional clinical trials.
  • This can result in wasted resources and negatively impact patient outcomes.

Purpose of the Study:

  • To propose a novel variable importance parameter for directly assessing predictive biomarker importance.
  • To develop a flexible nonparametric inference procedure for this estimand with robust statistical guarantees.
  • To improve the accuracy of predictive biomarker identification compared to existing treatment rule estimation methods.

Main Methods:

  • Development of a double robust and asymptotically linear estimator for the variable importance parameter.
  • Nonparametric inference procedure designed for high-dimensional covariate data.
  • Validation through extensive simulations mirroring randomized controlled trials.
  • Application to metastatic renal cell carcinoma tumor gene expression data.

Main Results:

  • The proposed method demonstrates superior ability in discerning predictive from nonpredictive biomarkers.
  • Simulation studies confirm the estimator's validity and performance in moderate and high-dimensional settings.
  • Analysis of metastatic renal cell carcinoma data identified key predictive biomarkers.

Conclusions:

  • The novel variable importance parameter and inference procedure offer a more accurate approach to predictive biomarker discovery.
  • This method enhances the efficiency of drug target identification and diagnostic assay development.
  • An open-source R package (uniCATE) is available for implementing the methodology.